The fast-fashion giant's long-awaited listing lands at a steep discount to its private-market heyday, resetting expectations for investors and rivals.

A failed late-stage heart study triggered a swift market punishment, forcing investors and boards to reset timelines and risk.

Elon Musk’s company is moving faster toward a market debut that could reset expectations for private space valuations and investor demand.